the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0234] At room temperature, 4-hydroxybenzaldehyde (1) (5g, 40.9mmol) was dissolved in anhydrousdichloromethane, protected by argon, and then 3,4-dihydro-2H-pyran (5.6mL, 61.4mmol ) and pyridinium p-toluenesulfonate (0.5g, 2mmol). Stir overnight at room temperature, and the reaction solution is successively washed with saturated NaHCO 3 solution and saturated brine three times, anhydrous Na 2 SO 4 Dried, then filtered and spin-dried, and separated by column chromatography to obtain 8.3 g (98%) of the product.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a compound used as an estrogen-related receptorregulator and an application of the compound. The compound is a 1-hydrogen-1, 2, 3-triazole compound with a structure as shown in formula (I) as well as pharmaceutical acceptable salt or prodrug molecule. The compound as well as pharmaceutical acceptable salt or prodrug molecule can be used for preparing drugs for adjusting activity of estrogen relevant receptor (ERR), preventing and treating breast cancer (comprising diseases which are free of influence of an anti-estrogen method), prostatic cancer or metabolic diseases. The formula (I) is as shown in the specification.
Description
technical field [0001] The invention belongs to the field of medicinal chemistry, and particularly relates to a compound used as an estrogen-related receptor modulator and its application in treating, improving, preventing or inhibiting diseases mediated by ERR activity. Background technique [0002] Whether in the world or in China, chronic diseases represented by malignant tumors, cardiovascular diseases and diabetes are becoming more important long-term threats. On May 19, 2008, the World Health Organization clearly pointed out in its latest report that non-communicable diseases are becoming the deadliest "killer" of human beings. Among them, cancer ranks first. In 2004, 7.4 million people died of cancer worldwide. Among breast cancer types, triple-negative breast cancer (TNBC) and basal-like breast cancer (BLBC) do not express estrogen receptor (ERα), androgen receptor (PR), and human epidermal growth factor receptor-2 (HER -2). There is currently no effective treatm...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.